Shares of Stericycle Inc (NASDAQ:SRCL) have been given a consensus rating of “Hold” by the twelve analysts that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $78.17.
Several research firms recently commented on SRCL. BidaskClub lowered shares of Stericycle from a “buy” rating to a “hold” rating in a report on Friday, May 25th. Barrington Research reaffirmed a “buy” rating on shares of Stericycle in a report on Friday, June 1st. BMO Capital Markets increased their target price on shares of Stericycle from $64.00 to $67.00 and gave the company a “market perform” rating in a report on Friday, May 4th. Royal Bank of Canada reduced their target price on shares of Stericycle from $75.00 to $61.00 and set an “underperform” rating on the stock in a report on Thursday, February 22nd. Finally, ValuEngine lowered shares of Stericycle from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 2nd.
Shares of Stericycle traded up $1.09, hitting $64.26, on Friday, Marketbeat reports. 941,700 shares of the company traded hands, compared to its average volume of 933,281. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.81 and a current ratio of 0.81. Stericycle has a 12-month low of $56.64 and a 12-month high of $83.25. The stock has a market cap of $5.38 billion, a P/E ratio of 14.81, a price-to-earnings-growth ratio of 1.41 and a beta of 0.41.
Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, May 3rd. The business services provider reported $1.21 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.05 by $0.16. Stericycle had a net margin of 0.19% and a return on equity of 14.14%. The company had revenue of $895.00 million for the quarter, compared to analyst estimates of $880.48 million. During the same quarter last year, the firm earned $1.09 EPS. The firm’s quarterly revenue was up .3% compared to the same quarter last year. analysts predict that Stericycle will post 4.63 earnings per share for the current year.
In other Stericycle news, CEO Charles A. Alutto sold 14,000 shares of the firm’s stock in a transaction on Tuesday, May 22nd. The shares were sold at an average price of $64.02, for a total value of $896,280.00. Following the sale, the chief executive officer now owns 18,026 shares of the company’s stock, valued at approximately $1,154,024.52. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Charles A. Alutto sold 13,000 shares of the firm’s stock in a transaction on Tuesday, May 29th. The stock was sold at an average price of $62.68, for a total transaction of $814,840.00. Following the completion of the sale, the chief executive officer now directly owns 17,026 shares in the company, valued at approximately $1,067,189.68. The disclosure for this sale can be found here. In the last three months, insiders sold 46,834 shares of company stock worth $2,966,543. Insiders own 3.50% of the company’s stock.
A number of institutional investors have recently made changes to their positions in the business. Cornerstone Capital Management Holdings LLC. boosted its stake in shares of Stericycle by 11.8% during the 4th quarter. Cornerstone Capital Management Holdings LLC. now owns 16,051 shares of the business services provider’s stock valued at $1,090,000 after purchasing an additional 1,690 shares in the last quarter. Roberts Glore & Co. Inc. IL bought a new stake in shares of Stericycle during the 4th quarter valued at about $210,000. W.G. Shaheen & Associates DBA Whitney & Co boosted its stake in shares of Stericycle by 2,001.2% during the 4th quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 71,967 shares of the business services provider’s stock valued at $4,893,000 after purchasing an additional 68,542 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of Stericycle by 48.6% during the 4th quarter. Wells Fargo & Company MN now owns 2,821,600 shares of the business services provider’s stock valued at $191,840,000 after purchasing an additional 922,641 shares in the last quarter. Finally, Investors Research Corp bought a new stake in shares of Stericycle during the 4th quarter valued at about $212,000. 97.50% of the stock is currently owned by institutional investors and hedge funds.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.